ARTICLE | Clinical News
Adamis, Colby preclinical data
August 1, 2011 7:00 AM UTC
In mouse models of androgen-dependent prostate cancer and castration resistant prostate cancer (CRPC), APC-300 reduced tumor growth and prostate-specific antigen ( KLK3; PSA). APC-300 also decreased ...